<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04875390</url>
  </required_header>
  <id_info>
    <org_study_id>ESP</org_study_id>
    <nct_id>NCT04875390</nct_id>
  </id_info>
  <brief_title>Erector Spina Plane (ESP) Block in Pediatric Patients</brief_title>
  <official_title>Evaluation of the Effect of Ultrasonographic Guided Erector Spina Plan Block Application on Postoperative Analgesia in Infants Undergoing Laparotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we aimed to evaluate the erector spina plane (ESP) block method that we used&#xD;
      in our clinic with ultrasonography in pediatric cases between 1 month and 2 years of age who&#xD;
      underwent laparotomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      36 patients who will undergo laparotomy between the ages of 1 month and 2 years in ASA (&#xD;
      American Society of Anesthesiologists) I-II class will be included in the study. patients&#xD;
      will be divided into 2 groups. Intraoperative erector spina plane block will be applied to&#xD;
      the 1st group (group E) and intraoperative local anesthetic infiltration will be applied to&#xD;
      the 2nd group (group L). Postoperative pain will be evaluated with the FLACC (face, legs,&#xD;
      activity, crying, consolation) scale.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 14, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the 6th hour pediatric pain scale, face ,legs , activity; cry;consolability (FLACC)</measure>
    <time_frame>6th hour</time_frame>
    <description>FLACC : Each of the five categories (F)face; (L)legs; (A)activity; (C)cry; (C)consolability is scored from 0-2 which results in a total score between 0 and 10. 0:relaxed and comfortable, 1-3: mild discomfortable, 4-6: moderate pain, 7-10: severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>paracetamol consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>the total number of paracetamol requirements in the first 24 hours in all patients</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Acute Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>group E</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intraoperative Erector spina plane block ( 0.3 ml/kg bupivacaine 0.25% at thoracic level 7 and 0.3 ml/kg bupivacaine 0.25% bupivacaine at thoracic level 11, totaling 0.6 ml/kg of 0.25% bupivacaine) will be performed after the surgery is completed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group L</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intraoperative local infiltration (0.6 ml/kg of 0.25% bupivacaine will be given to the wound lips at the end of the surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Erector spina plane block</intervention_name>
    <description>After the surgery is completed, intraoperative Erector spina plane block will be performed</description>
    <arm_group_label>group E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local infiltration</intervention_name>
    <description>After the surgery is completed, intraoperative local infiltration will be performed</description>
    <arm_group_label>group L</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1 month and 2 years of age&#xD;
&#xD;
          -  ASA (American Society of Anesthesiologists) I-II class&#xD;
&#xD;
          -  Patients who underwent nephrectomy, pyeloplasty, adrenal tumor excision with&#xD;
             unilateral paramedian incision&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent laparotomy with a midline incision&#xD;
&#xD;
          -  Local infection at the injection site,&#xD;
&#xD;
          -  Anatomical anomalies&#xD;
&#xD;
          -  Allergies to local anesthetics,&#xD;
&#xD;
          -  Coagulopathy,&#xD;
&#xD;
          -  Liver, kidney failure patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hülya Kaşıkara</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sengül Özmert</last_name>
    <role>Study Director</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Feyza Sever</last_name>
    <role>Study Director</role>
    <affiliation>Ankara City Hospital Bilkent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Halil Kara</last_name>
    <role>Study Director</role>
    <affiliation>Yıldırım Beyazıt University Medical Pharmacology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hülya Kaşıkara</last_name>
    <phone>05052712402</phone>
    <email>dr.hulyakasikara@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sengül Özmert</last_name>
    <phone>05323861201</phone>
    <email>sengulozmert@yahoo.com.tr</email>
  </overall_contact_backup>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 1, 2021</study_first_submitted>
  <study_first_submitted_qc>May 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>erector spina plane block</keyword>
  <keyword>pediatric patient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

